Recommendation	Consensus statement instruction	Ref
RCM genetic testing may be considered for patients in whom a cardiologist has established a clinical diagnosis of RCM based on examination of the patient’s clinical history, family history, and electrocardiographic/echocardiographic phenotype.		402, 404–406
Genetic testing specifically for TTR pathogenic variants is recommended for patients with RCM and a clinical diagnosis of cardiac TTR amyloidosis.		407, 408
Variant-specific genetic testing may be considered for family members and appropriate relatives following the identification of the disease-causative variant.		Expert opinion